|
1
|
World Health Organization: Information on
Mental Disorders. Available from: http://www.who.int/mental_health/management/depression/definition/en/index.
|
|
2
|
Zhang FF, Peng W, Sweeney JA, Jia ZY and
Gong QY: Brain structure alterations in depression:
Psychoradiological evidence. CNS Neurosci Ther. 24:994–1003.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Geerlings MI and Gerritsen L: Late-life
depression, hippocampal volumes, and hypothalamic-pituitary-adrenal
axis regulation: A systematic review and meta-analysis. Biol
Psychiatry. 82:339–350. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Campbell S, Marriott M, Nahmias C and
MacQueen GM: Lower hippocampal volume in patients suffering from
depression: A meta-analysis. Am J Psychiatry. 161:598–607.
2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Eker C and Gonul AS: Volumetric MRI
studies of the hippocampus in major depressive disorder: Meanings
of inconsistency and directions for future research. World J Biol
Psychiatry. 11:19–35. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Trifu S: Neuroendocrine insights into
burnout syndrome. Acta Endocrinol (Bucur). 15:404–405.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Srivastava S, Bhatia MS, Bhargava SK,
Kumari R and Chandra S: A diffusion tensor imaging study using a
voxel-based analysis, region-of-interest method to analyze white
matter abnormalities in first-episode, treatment-naïve major
depressive disorder. J Neuropsychiatry Clin Neurosci. 28:131–137.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bora E, Fornito A, Pantelis C and Yücel M:
Gray matter abnormalities in major depressive disorder: A
meta-analysis of voxel based morphometry studies. J Affect Disord.
138:9–18. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ramezani M, Abolmaesumi P, Tahmasebi A,
Bosma R, Tong R, Hollenstein T, Harkness K and Johnsrude I: Fusion
analysis of first episode depression: Where brain shape
deformations meet local composition of tissue. Neuroimage Clin.
7:114–121. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Foland-Ross LC, Sacchet MD, Prasad G,
Gilbert B, Thompson PM and Gotlib IH: Cortical thickness predicts
the first onset of major depression in adolescence. Int J Dev
Neurosci. 46:125–131. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shen Z, Cheng Y, Yang S, Dai N, Ye J, Liu
X, Lu J, Li N, Liu F, Lu Y, et al: Changes of grey matter volume in
first-episode drug-naive adult major depressive disorder patients
with different age-onset. Neuroimage Clin. 12:492–498.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kong L, Wu F, Tang Y, Ren L, Kong D, Liu
Y, Xu K and Wang F: Frontal-subcortical volumetric deficits in
single episode, medication-naïve depressed patients and the effects
of 8 weeks fluoxetine treatment: A VBM-DARTEL study. PLoS One.
9(e79055)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lu Y, Liang H, Han D, Mo Y, Li Z, Cheng Y,
Xu X, Shen Z, Tan C, Zhao W, et al: The volumetric and shape
changes of the putamen and thalamus in first episode, untreated
major depressive disorder. Neuroimage Clin. 11:658–666.
2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang H, Li L, Wu M, Chen Z, Hu X, Chen Y,
Zhu H, Jia Z and Gong Q: Brain gray matter alterations in first
episodes of depression: A meta-analysis of whole-brain studies.
Neurosci Biobehav Rev. 60:43–50. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jacobs RH, Barba A, Gowins JR, Klumpp H,
Jenkins LM, Mickey BJ, Ajilore O, Peciña M, Sikora M, Ryan KA, et
al: Decoupling of the amygdala to other salience network regions in
adolescent-onset recurrent major depressive disorder. Psychol Med.
46:1055–1067. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dombrovski AY, Siegle GJ, Szanto K, Clark
L, Reynolds CF and Aizenstein H: The temptation of suicide:
Striatal gray matter, discounting of delayed rewards, and suicide
attempts in late-life depression. Psychol Med. 42:1203–1215.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wagner G, Koch K, Schachtzabel C, Schultz
CC, Sauer H and Schlösser RG: Structural brain alterations in
patients with major depressive disorder and high risk for suicide:
Evidence for a distinct neurobiological entity? Neuroimage.
54:1607–1614. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Forbes EE, Hariri AR, Martin SL, Silk JS,
Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA and
Dahl RE: Altered striatal activation predicting real-world positive
affect in adolescent major depressive disorder. Am J Psychiatry.
166:64–73. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang XH, Wang Y, Huang J, Zhu CY, Liu XQ,
Cheung EF, Xie GR and Chan RC: Increased prefrontal and parietal
cortical thickness does not correlate with anhedonia in patients
with untreated first-episode major depressive disorders. Psychiatry
Res. 234:144–151. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen Z, Peng W, Sun H, Kuang W, Li W, Jia
Z and Gong Q: High-field magnetic resonance imaging of structural
alterations in first-episode, drug-naive patients with major
depressive disorder. Transl Psychiatry. 6(e942)2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sliz D and Hayley S: Major depressive
disorder and alterations in insular cortical activity: A review of
current functional magnetic imaging research. Front Hum Neurosci.
6(323)2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lange C and Irle E: Enlarged amygdala
volume and reduced hippocampal volume in young women with major
depression. Psychol Med. 34:1059–1064. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Frodl T, Meisenzahl E, Zetzsche T,
Bottlender R, Born C, Groll C, Jäger M, Leinsinger G, Hahn K and
Möller HJ: Enlargement of the amygdala in patients with a first
episode of major depression. Biol Psychiatry. 51:708–714.
2002.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Drevets WC, Videen TO, Price JL, Preskorn
SH, Carmichael ST and Raichle ME: A functional anatomical study of
unipolar depression. J Neurosci. 12:3628–3641. 1992.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vyas A, Jadhav S and Chattarji S:
Prolonged behavioral stress enhances synaptic connectivity in the
basolateral amygdala. Neuroscience. 143:387–393. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Abercrombie HC, Schaefer SM, Larson CL,
Oakes TR, Lindgren KA, Holden JE, Perlman SB, Turski PA, Krahn DD,
Benca RM and Davidson RJ: Metabolic rate in the right amygdala
predicts negative affect in depressed patients. Neuroreport.
9:3301–3307. 1998.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Conrad CD, LeDoux JE, Magariños AM and
McEwen BS: Repeated restraint stress facilitates fear conditioning
independently of causing hippocampal CA3 dendritic atrophy. Behav
Neurosci. 113:902–913. 1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Merzenich M: Soft-Wired: How the new
science of brain plasticity can change your life. San Francisco:
Parnassus Publishing, 2013.
|
|
29
|
Eriksson PS, Perfilieva E, Björk-Eriksson
T, Alborn AM, Nordborg C, Peterson DA and Gage FH: Neurogenesis in
the adult human hippocampus. Nat Med. 4:1313–1317. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Albert PR: Adult neuroplasticity: A new
‘cure’ for major depression? J Psychiatry Neurosci. 44:147–150.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sapolsky RM: Glucocorticoids and
hippocampal atrophy in neuropsychiatric disorders. Arch Gen
Psychiatry. 57:925–935. 2000.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Woolley CS, Gould E and McEwen BS:
Exposure to excess glucocorticoids alters dendritic morphology of
adult hippocampal pyramidal neurons. Brain Res. 531:225–231.
1990.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Duman RS: Depression: A case of neuronal
life and death? Biol Psychiatry. 56:140–145. 2004.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Virgin CE Jr, Ha TP, Packan DR, Tombaugh
GC, Yang SH, Horner HC and Sapolsky RM: Glucocorticoids inhibit
glucose transport and glutamate uptake in hippocampal astrocytes:
Implications for glucocorticoid neurotoxicity. J Neurochem.
57:1422–1428. 1991.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Radley JJ, Sisti HM, Hao J, Rocher AB,
McCall T, Hof PR, McEwen BS and Morrison JH: Chronic behavioral
stress induces apical dendritic reorganization in pyramidal neurons
of the medial prefrontal cortex. Neuroscience. 125:1–6.
2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wellman CL: Dendritic reorganization in
pyramidal neurons in medial prefrontal cortex after chronic
corticosterone administration. J Neurobiol. 49:245–253.
2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Radley JJ, Rocher AB, Rodriguez A,
Ehlenberger DB, Dammann M, McEwen BS, Morrison JH, Wearne SL and
Hof PR: Repeated stress alters dendritic spine morphology in the
rat medial prefrontal cortex. J Comp Neurol. 507:1141–1150.
2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Furini C, Myskiw J and Izquierdo I: The
learning of fear extinction. Neurosci Biobehav Rev. 47:670–683.
2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Izquierdo A, Wellman CL and Holmes A:
Brief uncontrollable stress causes dendritic retraction in
infralimbic cortex and resistance to fear extinction in mice. J
Neurosci. 26:5733–5738. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Dibbets P, van den Broek A and Evers EA:
Fear conditioning and extinction in anxiety- and depression-prone
persons. Memory. 23:350–364. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mayberg HS, Liotti M, Brannan SK, McGinnis
S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC,
Lancaster JL and Fox PT: Reciprocal limbic-cortical function and
negative mood: Converging PET findings in depression and normal
sadness. Am J Psychiatry. 156:675–682. 1999.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mutschler I, Ball T, Wankerl J and Strigo
IA: Pain and emotion in the insular cortex: Evidence for functional
reorganization in major depression. Neurosci Lett. 520:204–209.
2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Raichle ME, MacLeod AM, Snyder AZ, Powers
WJ, Gusnard DA and Shulman GL: A default mode of brain function.
Proc Natl Acad Sci USA. 98:676–682. 2001.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Jovanov E: On physiological bases of
states of expanded in consciousness. In: State of consciousness.
Experimental insights into meditation, walking, sleeping and
dreams. Cvetkovic D and Cosic I (eds). Springer-Verlag Berlin
Heidelberg, New York, NY, pp203-223, 2011.
|
|
45
|
Hamilton JP, Farmer M, Fogelman P and
Gotlib IH: Depressive rumination, the default-mode network, and the
dark matter of clinical neuroscience. Biol Psychiatry. 78:224–230.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Williams LM: Precision psychiatry: A
neural circuit taxonomy for depression and anxiety. Lancet
Psychiatry. 3:472–480. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Dragoi AM, Radulescu I, Năsui BA, Pop AL,
Varlas VN and Trifu S: Clozapine: An updated overview of
pharmacogenetic biomarkers, risks, and safety-particularities in
the context of COVID-19. Brain Sci. 10(840)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Pop AL, Crişan S, Bârcă M, Ciobanu AM,
Varlas VN, Pop C, Pali MA, Cauni D, Ozon EA, Udeanu D, et al:
Evaluation of dissolution profiles of a newly developed solid oral
immediate-release formula containing alpha-lipoic acid. Processes.
9(176)2021.
|
|
49
|
Zarei M, Johansen-Berg H, Smith S,
Ciccarelli O, Thompson AJ and Matthews PM: Functional anatomy of
interhemispheric cortical connections in the human brain. J Anat.
209:311–320. 2006.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Serafini G: Neuroplasticity and major
depression, the role of modern antidepressant drugs. World J
Psychiatry. 2:49–57. 2012.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Popov VI, Bocharova LS and Bragin AG:
Repeated changes of dendritic morphology in the hippocampus of
ground squirrels in the course of hibernation. Neuroscience.
48:45–51. 1992.PubMed/NCBI View Article : Google Scholar
|
|
52
|
McEwen BS, Nasca C and Gray JD: Stress
effects on neuronal structure: Hippocampus, amygdala, and
prefrontal cortex. Neuropsychopharmacology. 41:3–23.
2016.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Fuchs E: Neuroplasticity: A new approach
to the pathophysiology of depression. In: Neuroplasticity: New
biochemical mechanisms. Costa e Silva JA, Macher JP and Olie JP
(eds). Springer, London, pp1-12, 2009.
|
|
54
|
Jay TM: Cellular plasticity and the
pathophysiology of depression. In: Neuroplasticity: New Biochemical
Mechanisms. Costa e Silva JA, Macher JP and Olie JP (eds).
Springer, London, pp41-55, 2009.
|
|
55
|
Waløen K, Kleppe R, Martinezand A and
Haavik J: Tyrosine and tryptophan hydroxylases as therapeutic
targets in human disease. Expert Opin Ther Targets. 21:167–180.
2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Peyrovian B, Rosenblat JD, Pan Z,
Iacobucci M, Brietzke E and McIntyre RS: The glycine site of NMDA
receptors: A target for cognitive enhancement in psychiatric
disorders. Prog Neuropsychopharmacol Biol Psychiatry. 92:387–404.
2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Saldanha D, Kumar N, Ryali V, Srivastava K
and Pawar AA: Serum serotonin abnormality in depression. Med J
Armed Forces India. 65:108–112. 2009.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Villas-Boas GR, Lavorato SN, Paes MM, de
Carvalho PMG, Rescia VC, Cunha MS, de Magalhães-Filho MF, Ponsoni
LF, de Carvalho AAV, de Lacerda RB, et al: Modulation of the
serotonergic receptosome in the treatment of anxiety and
depression: A narrative review of the experimental evidence.
Pharmaceuticals (Basel). 14(148)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Tang L, Wang Y, Chen Y, Chen L, Zheng S,
Bao M, Xiang J, Luo H, Li J and Li Y: The association between 5HT2A
T102C and behavioral and psychological symptoms of dementia in
Alzheimer's disease: A meta-analysis. Biomed Res Int.
2017(5320135)2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Liu Y, Zhao J and Guo W: Emotional roles
of mono-aminergic neurotransmitters in major depressive disorder
and anxiety disorders. Front Psychol. 9(2201)2018.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Cervenka S, Hedman E, Ikoma Y, Djurfeldt
DR, Rück C, Halldin C and Lindefors N: Changes in dopamine
D2-receptor binding are associated to symptom reduction after
psychotherapy in social anxiety disorder. Transl Psychiatry.
2(e120)2012.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Pöldinger W, Calanchini B and Schwarz W: A
functional-dimensional approach to depression: Serotonin deficiency
as a target syndrome in a comparison of 5-hydroxytryptophan and
fluvoxamine. Psychopathology. 24:53–81. 1991.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Bromberg-Martin ES, Matsumoto M and
Hikosaka O: Dopamine in motivational control: Rewarding, aversive,
and alerting. Neuron. 68:815–834. 2010.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Olguín HJ, Guzmán DC, García EH and Mejía
GB: The role of dopamine and its dysfunction as a consequence of
oxidative stress. Oxid Med Cell Longev.
2016(9730467)2016.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Moret C and Briley M: The importance of
norepinephrine in depression. Neuropsychiatr Dis Treat. 7 (Suppl
1):S9–S13. 2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Coppen A: The biochemistry of affective
disorders. Br J Psychiatry. 113:1237–1264. 1967.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Cowen PJ and Browning M: What has
serotonin to do with depression? World Psychiatry. 14:158–160.
2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Pivonello R, De Leo M, Cozzolino A and
Colao A: The treatment of cushing's disease. Endocr Rev.
36:385–486. 2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Nandam LS, Brazel M, Zhou M and Jhaveri
DJ: Cortisol and major depressive disorder-translating findings
from humans to animal models and back. Front Psychiatry.
10(974)2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Juruena MF, Agustini B, Cleare AJ and
Young AH: A translational approach to clinical practice via
stress-responsive glucocorticoid receptor signaling. Stem Cell
Investig. 4(13)2017.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Delaveau P, Jabourian M, Lemogne C,
Guionnet S, Bergouignan L and Fossati P: Brain effects of
antidepressants in major depression: A meta-analysis of emotional
processing studies. J Affect Disord. 130:66–74. 2011.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Yan HC, Cao X, Gao TM and Zhu XH:
Promoting adult hippocampal neurogenesis: A novel strategy for
antidepressant drug screening. Curr Med Chem. 18:4359–4367.
2011.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Dranovsky A and Hen R: Hippocampal
neurogenesis: Regulation by stress and antidepressants. Biol
Psychiatry. 59:1136–1143. 2006.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Wagner G, Koch K, Schachtzabel C, Sobanski
T, Reichenbach JR, Sauer H and Schlösser RG: Differential effects
of serotonergic and noradrenergic antidepressants on brain activity
during a cognitive control task and neurofunctional prediction of
treatment outcome in patients with depression. J Psychiatry
Neurosci. 35:247–257. 2010.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Andrade C and Rao NS: How antidepressant
drugs act: A primer on neuroplasticity as the eventual mediator of
antidepressant efficacy. Indian J Psychiatry. 52:378–386.
2010.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Trifu S, Carp EG and Nadoleanu A: Alcohol
as a substitute, mask of depression and ‘antidote’ of narcissism.
Eur Proc Soc Behav Sci. 31:986–994. 2017.
|
|
77
|
Magariños AM, Deslandes A and McEwen BS:
Effects of antidepressants and benzodiazepine treatments on the
dendritic structure of CA3 pyramidal neurons after chronic stress.
Eur J Pharmacol. 371:113–122. 1999.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Cattaneo A, Bocchio-Chiavetto L, Zanardini
R, Milanesi E, Placentino A and Gennarelli M: Reduced peripheral
brain-derived neurotrophic factor mRNA levels are normalized by
antidepressant treatment. Int J Neuropsychopharmacol. 13:103–108.
2010.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Santarelli L, Saxe M, Gross C, Surget A,
Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, et
al: Requirement of hippocampal neurogenesis for the behavioral
effects of antidepressants. Science. 301:805–809. 2003.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Nestler EJ and Carlezon WA Jr: The
mesolimbic dopamine reward circuit in depression. Biol Psychiatry.
59:1151–1159. 2006.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Watanabe Y, Gould E, Daniels DC, Cameron H
and McEwen BS: Tianeptine attenuates stress-induced morphological
changes in the hippocampus. Eur J Pharmacol. 222:157–162.
1992.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Bonanno G, Giambelli R, Raiteri L,
Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G and
Popoli M: Chronic antidepressants reduce depolarization-evoked
glutamate release and protein interactions favoring formation of
SNARE complex in hippocampus. J Neurosci. 25:3270–3279.
2005.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Malberg JE, Eisch AJ, Nestler EJ and Duman
RS: Chronic antidepressant treatment increases neurogenesis in
adult rat hippocampus. J Neurosci. 20:9104–9110. 2000.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Rocher C, Spedding M, Munoz C and Jay TM:
Acute stress-induced changes in hippocampal/prefrontal circuits in
rats: Effects of antidepressants. Cereb Cortex. 14:224–229.
2004.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Newport DJ, Carpenter LL, McDonald WM,
Potash JB, Tohen M and Nemeroff CB: APA Council of Research Task
Force on Novel Biomarkers and Treatments. Ketamine and other NMDA
antagonists: Early clinical trials and possible mechanisms in
depression. Am J Psychiatry. 172:950–966. 2015.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Hayley S and Litteljohn D: Neuroplasticity
and the next wave of antidepressant strategies. Front Cell
Neurosci. 7(218)2013.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Gigliucci V, O'Dowd G, Casey S, Egan D,
Gibney S and Harkin A: Ketamine elicits sustained
antidepressant-like activity via a serotonin-dependent mechanism.
Psychopharmacology (Berl). 228:157–166. 2013.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Tan S, Lam WP, Wai MS, Yu WH and Yew DT:
Chronic ketamine administration modulates midbrain dopamine system
in mice. PLoS One. 7(e43947)2012.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM,
Iwata M, Li XY, Aghajanian G and Duman RS: mTOR-dependent synapse
formation underlies the rapid antidepressant effects of NMDA
antagonists. Science. 329:959–964. 2010.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Loo C, Simpson B and MacPherson R:
Augmentation strategies in electroconvulsive therapy. J ECT.
26:202–207. 2010.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Singh A and Kar SK: How electroconvulsive
therapy works?: Understanding the neurobiological mechanisms. Clin
Psychopharmacol Neurosci. 15:210–221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Cano M, Cardoner N, Urretavizcaya M,
Martínez-Zalacaín I, Goldberg X, Via E, Contreras-Rodríguez O,
Camprodon J, de Arriba-Arnau A, Hernández-Ribas R, et al:
Modulation of limbic and prefrontal connectivity by
electroconvulsive therapy in treatment-resistant depression: A
preliminary study. Brain Stimul. 9:65–71. 2016.PubMed/NCBI View Article : Google Scholar
|
